Takeda Pharmaceutical (TKPHF) Change in Acquisitions & Divestments (2018 - 2026)

Takeda Pharmaceutical's Change in Acquisitions & Divestments history runs 9 years deep, the most recent figure standing at -$394.2 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 190.98% year-over-year to -$394.2 million; the TTM figure through Mar 2026 stood at -$320.5 million (down 250.52% YoY), while the FY2026 annual figure was -$314.1 million, down 198.07% from the prior year.
• Change in Acquisitions & Divestments was -$394.2 million for Q1 2026 at Takeda Pharmaceutical, down from $320.6 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $433.3 million in Q1 2025 to a low of -$705.2 million in Q2 2024.
• Historically, Change in Acquisitions & Divestments has averaged -$32.7 million across 5 years, with a median of -$22.8 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Change in Acquisitions & Divestments sank 707.49% in 2023, then surged 642.07% in 2025.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $234.6 million in 2022, then decreased by 21.76% to $183.6 million in 2023, then jumped by 33.53% to $245.1 million in 2024, then soared by 30.79% to $320.6 million in 2025, then slumped by 222.98% to -$394.2 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at -$394.2 million (Q1 2026), $320.6 million (Q4 2025), and $350.4 million (Q3 2025), per Business Quant data.